| UniProt ID | STAM1_HUMAN | |
|---|---|---|
| UniProt AC | Q92783 | |
| Protein Name | Signal transducing adapter molecule 1 | |
| Gene Name | STAM | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 540 | |
| Subcellular Localization |
Cytoplasm . Early endosome membrane Peripheral membrane protein Cytoplasmic side . |
|
| Protein Description | Involved in intracellular signal transduction mediated by cytokines and growth factors. Upon IL-2 and GM-CSL stimulation, it plays a role in signaling leading to DNA synthesis and MYC induction. May also play a role in T-cell development. Involved in down-regulation of receptor tyrosine kinase via multivesicular body (MVBs) when complexed with HGS (ESCRT-0 complex). The ESCRT-0 complex binds ubiquitin and acts as sorting machinery that recognizes ubiquitinated receptors and transfers them to further sequential lysosomal sorting/trafficking processes.. | |
| Protein Sequence | MPLFATNPFDQDVEKATSEMNTAEDWGLILDICDKVGQSRTGPKDCLRSIMRRVNHKDPHVAMQALTLLGACVSNCGKIFHLEVCSRDFASEVSNVLNKGHPKVCEKLKALMVEWTDEFKNDPQLSLISAMIKNLKEQGVTFPAIGSQAAEQAKASPALVAKDPGTVANKKEEEDLAKAIELSLKEQRQQSTTLSTLYPSTSSLLTNHQHEGRKVRAIYDFEAAEDNELTFKAGEIITVLDDSDPNWWKGETHQGIGLFPSNFVTADLTAEPEMIKTEKKTVQFSDDVQVETIEPEPEPAFIDEDKMDQLLQMLQSTDPSDDQPDLPELLHLEAMCHQMGPLIDEKLEDIDRKHSELSELNVKVMEALSLYTKLMNEDPMYSMYAKLQNQPYYMQSSGVSGSQVYAGPPPSGAYLVAGNAQMSHLQSYSLPPEQLSSLSQAVVPPSANPALPSQQTQAAYPNTMVSSVQGNTYPSQAPVYSPPPAATAAAATADVTLYQNAGPNMPQVPNYNLTSSTLPQPGGSQQPPQPQQPYSQKALL | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 6 | Phosphorylation | --MPLFATNPFDQDV --CCCCCCCCCCHHH | 35.77 | 25599653 | |
| 17 | Phosphorylation | DQDVEKATSEMNTAE CHHHHHHHHHCCCHH | 35.97 | 28111955 | |
| 18 | Phosphorylation | QDVEKATSEMNTAED HHHHHHHHHCCCHHH | 39.44 | 28111955 | |
| 22 | Phosphorylation | KATSEMNTAEDWGLI HHHHHCCCHHHHHHH | 30.07 | 28111955 | |
| 39 | Phosphorylation | ICDKVGQSRTGPKDC HHHHHCCCCCCHHHH | 26.36 | 28111955 | |
| 41 | Phosphorylation | DKVGQSRTGPKDCLR HHHCCCCCCHHHHHH | 64.18 | 28111955 | |
| 91 | Phosphorylation | VCSRDFASEVSNVLN ECCHHHHHHHHHHHH | 38.23 | 21712546 | |
| 99 | Ubiquitination | EVSNVLNKGHPKVCE HHHHHHHCCCHHHHH | 55.20 | - | |
| 103 | Ubiquitination | VLNKGHPKVCEKLKA HHHCCCHHHHHHHHH | 54.57 | - | |
| 133 (in isoform 1) | Ubiquitination | - | 43.04 | 21890473 | |
| 133 (in isoform 2) | Ubiquitination | - | 43.04 | 21890473 | |
| 133 | Ubiquitination | SLISAMIKNLKEQGV HHHHHHHHHHHHCCC | 43.04 | 21890473 | |
| 133 | Ubiquitination | SLISAMIKNLKEQGV HHHHHHHHHHHHCCC | 43.04 | 21890473 | |
| 136 | Ubiquitination | SAMIKNLKEQGVTFP HHHHHHHHHCCCCCC | 58.34 | - | |
| 136 (in isoform 2) | Ubiquitination | - | 58.34 | - | |
| 141 | Phosphorylation | NLKEQGVTFPAIGSQ HHHHCCCCCCCCCHH | 30.63 | 23186163 | |
| 147 | Phosphorylation | VTFPAIGSQAAEQAK CCCCCCCHHHHHHHH | 15.55 | 23403867 | |
| 154 (in isoform 2) | Ubiquitination | - | 49.44 | 21890473 | |
| 154 | Ubiquitination | SQAAEQAKASPALVA HHHHHHHHCCCCEEC | 49.44 | 21890473 | |
| 154 (in isoform 1) | Ubiquitination | - | 49.44 | 21890473 | |
| 154 | Ubiquitination | SQAAEQAKASPALVA HHHHHHHHCCCCEEC | 49.44 | 21890473 | |
| 156 | Phosphorylation | AAEQAKASPALVAKD HHHHHHCCCCEECCC | 15.25 | 25159151 | |
| 162 (in isoform 1) | Ubiquitination | - | 57.91 | 21890473 | |
| 162 (in isoform 2) | Ubiquitination | - | 57.91 | 21890473 | |
| 162 | Ubiquitination | ASPALVAKDPGTVAN CCCCEECCCCCCCCC | 57.91 | 20639865 | |
| 170 (in isoform 1) | Ubiquitination | - | 52.39 | 21890473 | |
| 170 | Acetylation | DPGTVANKKEEEDLA CCCCCCCHHHHHHHH | 52.39 | 23749302 | |
| 170 (in isoform 2) | Ubiquitination | - | 52.39 | 21890473 | |
| 170 | Ubiquitination | DPGTVANKKEEEDLA CCCCCCCHHHHHHHH | 52.39 | 21906983 | |
| 171 (in isoform 2) | Ubiquitination | - | 70.89 | 21890473 | |
| 171 (in isoform 1) | Ubiquitination | - | 70.89 | 21890473 | |
| 171 | Ubiquitination | PGTVANKKEEEDLAK CCCCCCHHHHHHHHH | 70.89 | 21906983 | |
| 178 | Ubiquitination | KEEEDLAKAIELSLK HHHHHHHHHHHHHHH | 58.14 | - | |
| 183 | Phosphorylation | LAKAIELSLKEQRQQ HHHHHHHHHHHHHHH | 25.30 | 29514088 | |
| 185 (in isoform 1) | Ubiquitination | - | 48.72 | 21890473 | |
| 185 | Ubiquitination | KAIELSLKEQRQQST HHHHHHHHHHHHHHC | 48.72 | 21890473 | |
| 185 | Ubiquitination | KAIELSLKEQRQQST HHHHHHHHHHHHHHC | 48.72 | 21890473 | |
| 185 (in isoform 2) | Ubiquitination | - | 48.72 | 21890473 | |
| 191 | Phosphorylation | LKEQRQQSTTLSTLY HHHHHHHHCCHHHHC | 18.28 | 21945579 | |
| 192 | Phosphorylation | KEQRQQSTTLSTLYP HHHHHHHCCHHHHCC | 27.67 | 21945579 | |
| 193 | Phosphorylation | EQRQQSTTLSTLYPS HHHHHHCCHHHHCCC | 24.77 | 21945579 | |
| 195 | Phosphorylation | RQQSTTLSTLYPSTS HHHHCCHHHHCCCHH | 17.80 | 21945579 | |
| 196 | Phosphorylation | QQSTTLSTLYPSTSS HHHCCHHHHCCCHHH | 33.16 | 21945579 | |
| 198 | Phosphorylation | STTLSTLYPSTSSLL HCCHHHHCCCHHHHH | 8.67 | 21945579 | |
| 200 | Phosphorylation | TLSTLYPSTSSLLTN CHHHHCCCHHHHHHC | 27.62 | 21945579 | |
| 201 | Phosphorylation | LSTLYPSTSSLLTNH HHHHCCCHHHHHHCC | 20.17 | 21945579 | |
| 202 | Phosphorylation | STLYPSTSSLLTNHQ HHHCCCHHHHHHCCC | 24.27 | 21945579 | |
| 203 | Phosphorylation | TLYPSTSSLLTNHQH HHCCCHHHHHHCCCC | 27.73 | 21945579 | |
| 206 | Phosphorylation | PSTSSLLTNHQHEGR CCHHHHHHCCCCCCC | 35.63 | 21945579 | |
| 276 (in isoform 1) | Ubiquitination | - | 49.69 | 21890473 | |
| 276 (in isoform 2) | Ubiquitination | - | 49.69 | 21890473 | |
| 276 | Ubiquitination | TAEPEMIKTEKKTVQ CCCHHHCCCCCCEEE | 49.69 | 2190698 | |
| 276 | Sumoylation | TAEPEMIKTEKKTVQ CCCHHHCCCCCCEEE | 49.69 | 28112733 | |
| 279 (in isoform 2) | Ubiquitination | - | 60.00 | - | |
| 353 | Ubiquitination | KLEDIDRKHSELSEL HHHHHHHHCHHHHHH | 47.97 | - | |
| 353 (in isoform 2) | Ubiquitination | - | 47.97 | - | |
| 355 | Phosphorylation | EDIDRKHSELSELNV HHHHHHCHHHHHHHH | 43.18 | 28348404 | |
| 371 | Phosphorylation | VMEALSLYTKLMNED HHHHHHHHHHHCCCC | 9.84 | - | |
| 372 | Phosphorylation | MEALSLYTKLMNEDP HHHHHHHHHHCCCCC | 24.01 | - | |
| 381 | Phosphorylation | LMNEDPMYSMYAKLQ HCCCCCCHHHHHHHC | 8.82 | 21945579 | |
| 382 | Phosphorylation | MNEDPMYSMYAKLQN CCCCCCHHHHHHHCC | 10.08 | 21945579 | |
| 384 | Phosphorylation | EDPMYSMYAKLQNQP CCCCHHHHHHHCCCC | 8.47 | 21945579 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of STAM1_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of STAM1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of STAM1_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-156, AND MASSSPECTROMETRY. | |
| "An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells."; Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.; J. Proteome Res. 8:3852-3861(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-198 AND TYR-384, ANDMASS SPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-198, AND MASSSPECTROMETRY. | |
| "Time-resolved mass spectrometry of tyrosine phosphorylation sites inthe epidermal growth factor receptor signaling network reveals dynamicmodules."; Zhang Y., Wolf-Yadlin A., Ross P.L., Pappin D.J., Rush J.,Lauffenburger D.A., White F.M.; Mol. Cell. Proteomics 4:1240-1250(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-381, AND MASSSPECTROMETRY. | |
| "Tyrosine phosphorylation mapping of the epidermal growth factorreceptor signaling pathway."; Steen H., Kuster B., Fernandez M., Pandey A., Mann M.; J. Biol. Chem. 277:1031-1039(2002). Cited for: PROTEIN SEQUENCE OF 189-213, INTERACTION WITH HGS, CLEAVAGE OFINITIATOR METHIONINE, PHOSPHORYLATION AT TYR-198, AND MASSSPECTROMETRY. | |